Clinical Trials Sponsored by EBI, LLC dba Biomet Spine, Biomet Trauma, Biomet Osteobiologics and Biomet Br...
Total 0 results
Nothing found
Sponsors and Collaborators
- Victor Montori
- ProteoSys AG
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- AMTC & Associates
- Elim Pediatric Pharmaceuticals Inc.
- Caritas Freetown
- Rui-hua Xu, MD, PhD
- University Medical Center Goettingen
- The Fifth Affiliated Hospital of Zunyi Medical College
- Celtaxsys Aus Pty Limited
- CRMBM-CEMEREM
- Cardresearch
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- Diego Hernan Giunta, MD
- Societa Italiana di Endoscopia Digestiva
- Alberta Children's Hospital, Calgary, Canada
- Fondren Orthopedic Group L.L.P.
- San MediTech(Huzhou)Co.,Ltd.
- Norsk Proteinintolerance, Norway
- Donders Institute for Brain, Cognition and Behavior
- View Full List
Medical Conditions
- Gynecologic Cancer
- Tube Disorders Eustachian
- Plasmodium Falciparum Malaria (Drug Resistant)
- Non-dystrophic Myotonias
- Non-compressible Torso Hemorrhage
- Malignant Ascites Due to Epithelial Carcinoma
- Disturbance of Activity and Attention
- Atrial Fibrillation, Postoperative
- Prostate Cancer Recurrent
- Spermatogenesis Arrest
- Fever, Sweats, and Hot Flashes
- Auditory Hallucination, Verbal
- Normal Diameter of Optic Nerve
- Stereotactic Radioablation for Ventricular Tachycardia
- Tularaemia
- Postcomatose Unawareness State
- Orbital Tumor
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Lymphedema of Arm
- Fibromyalgia Syndrome, Primary
- View Full List
Drug Interventions
- PF-00868554
- Ruxolitinib
- Atezolizumab
- Indoximod
- SERETIDE Diskus
- Polyethylene glycol 3350
- Enzalutamide, Abiraterone
- Lamivudine
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Flibanserin 100 mg dose every evening
- Epimedium Prenylflavonoids Extract
- Cetrorelix 78 mg + 78 mg
- Insulin
- Mupirocin Calcium
- Oxycodone, fentanyl
- Cytarabine ARA-C
- Bortezomib/dexamethasone
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Topotecan
- Methotrexate
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Chile
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Egypt
- Contract Research Organizations in France
- Contract Research Organizations in Hungary
- Contract Research Organizations in Japan
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Philippines
- Contract Research Organizations in Suriname
- Contract Research Organizations in Ukraine
- Contract Research Organizations in Zambia
- CRO list by country